ARK Genomic Revolution ETF (ARKG) Holdings $20.94 -2.67 (-11.31%) Closing price 05/23/2025 03:59 PM EasternExtended Trading$20.82 -0.12 (-0.57%) As of 05/23/2025 07:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Holdings Stock AnalysisChartHeadlinesHoldingsOwnershipRatingsBuy This Stock Top 33 ARKG HoldingsRankCompanyCurrent PriceWeightShares Held1TEMTempus AI$62.56+5.6%10.07%1,516,7062CRSPCRISPR Therapeutics$36.86-1.8%7.97%2,002,1263TWSTTwist Bioscience$28.26+0.4%7.29%2,088,7804GHGuardant Health$38.00+2.6%5.94%1,345,8095NTRANatera$153.32+0.6%5.78%347,1116RXRXRecursion Pharmaceuticals$4.08-1.4%5.73%11,669,2487ADPTAdaptive Biotechnologies$8.93+1.0%5.48%5,436,0338SDGRSchrödinger$21.40+0.8%5.01%1,955,7439VCYTVeracyte$27.16-0.9%3.87%1,187,53710PSNLPersonalis$4.78+3.5%3.83%7,094,216 Get the Latest News and Ratings for ARKG and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ARK Genomic Revolution ETF and its competitors with MarketBeat's FREE daily newsletter. 11BEAMBeam Therapeutics$16.83-2.4%3.79%1,960,80312CDNACareDx$16.95-0.9%3.62%2,091,21013IONSIonis Pharmaceuticals$32.98-0.8%3.24%911,00114TXG10x Genomics$8.17-4.3%3.23%3,210,14315ABSIAbsci$2.663.00%9,665,88416NTLAIntellia Therapeutics$9.16-3.2%2.58%2,847,40117ARCTArcturus Therapeutics$12.20-4.7%2.10%1,709,64118ILMNIllumina$80.37-0.2%1.73%199,96219NRIXNurix Therapeutics$9.72-2.7%1.69%1,566,17020AMGNAmgen$271.66-0.1%1.68%57,67521MASS908 Devices$4.80+1.3%1.60%2,639,65422BFLYButterfly Network$2.18+1.9%1.59%6,393,00323PACBPacific Biosciences of California$0.92-2.1%1.31%11,212,74024QSIQuantum-Si$1.94+11.5%1.27%7,934,71025VEEVVeeva Systems$233.41-0.9%1.27%49,60626VRTXVertex Pharmaceuticals$436.00+0.5%1.11%23,93627CERSCerus$1.250.99%6,932,69928INCYIncyte$64.25-0.4%0.99%152,90529REGNRegeneron Pharmaceuticals$588.34-1.4%0.76%12,49830CMPSCOMPASS Pathways$4.36+4.3%0.68%1,643,58531LABStandard BioTools$0.92-3.4%0.39%3,144,13832PRMEPrime Medicine$1.29+4.9%0.33%2,313,45233GOLDMAN FS TRSY OBLIG INST 468N/A0.10%957,528 Geographic ExposureUnited States91.3%Switzerland8.2%Currency ExposureUSD99.6%Sector ExposureHealth Care86.4%Information Technology6.1%Consumer Discretionary5.7%Technology1.3%Industry ExposureBiotechnology42.8%Life Sciences Tools & Services24.4%Health Care Equipment & Supplies13.3%Health Care Providers & Services5.9%Diversified Consumer Services5.7%IT Services4.7%Electronic Equipment, Instruments & Components1.4%Software1.3%SubIndustry ExposureBiotechnology42.8%Life Sciences Tools & Services31.2%Health Care Equipment6.5%Health Care Services5.9%Internet Services & Infrastructure4.7%Electronic Equipment & Instruments1.4%Application Software1.3%Coupon Exposure4-60.1% Related Companies and Tools Related Companies ARK Fintech Innovation ETF Portfolio Global X S&P 500 Catholic Values ETF Portfolio ARK Autonomous Technology & Robotics ETF Portfolio iShares Cybersecurity and Tech ETF Portfolio ROBO Global Robotics & Automation ETF Portfolio iShares ESG MSCI USA Leaders ETF Portfolio iShares MSCI ACWI Low Carbon Target ETF Portfolio iShares Future AI & Tech ETF Portfolio Defiance Quantum ETF Portfolio Invesco NASDAQ Internet ETF Portfolio This page (BATS:ARKG) was last updated on 5/25/2025 by MarketBeat.com Staff From Our PartnersGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ARK Genomic Revolution ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share ARK Genomic Revolution ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
